Preoperative Anemia in Cardiac Operation: Does Hemoglobin Tell the Whole Story?

Annals of Thoracic Surgery

Volumn 105, Issue 1, 2018, Pages 100-107

  Dai, Lu ^a   Mick, Stephanie L ^b   McCrae, Keith R ^b   Houghtaling, Penny L ^b   Sabik, Joseph F ^b   Blackstone, Eugene H ^b   Koch, Colleen G ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ANEMIA; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DEATH; ERYTHROCYTE TRANSFUSION; FEMALE; HEART SURGERY; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MACROCYTIC ANEMIA; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MICROCYTIC ANEMIA; NORMOCYTIC ANEMIA; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; REOPERATION; BLOOD; COMPLICATION; HEART DISEASE; RETROSPECTIVE STUDY;

ANEMIA; CARDIAC SURGICAL PROCEDURES; ERYTHROCYTE INDICES; FEMALE; HEART DISEASES; HEMOGLOBINS; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 85034427767     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2017.06.074     Document Type: Article

References (40)

1. Hung, M., Besser, M., Sharples, L.D., Nair, S.K., Klein, A.A., The prevalence and association with transfusion, intensive care unit stay and mortality of pre-operative anaemia in a cohort of cardiac surgery patients. Anaesthesia 66 (2011), 812–818.
2. Miceli, A., Romeo, F., Glauber, M., de Siena, P.M., Caputo, M., Angelini, G.D., Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery. J Cardiothorac Surg, 9, 2014, 137.
3. Joshi, S.S., George, A., Manasa, D., Savita, H.M., Krishna, P.T., Jagadeesh, A.M., Propensity-matched analysis of association between preoperative anemia and in-hospital mortality in cardiac surgical patients undergoing valvular heart surgeries. Ann Card Anaesth 18 (2015), 373–379.
4. Spiegelstein, D., Holmes, S.D., Pritchard, G., Halpin, L., Ad, N., Preoperative hematocrit as a predictor of perioperative morbidities following nonemergent coronary artery bypass surgery. J Card Surg 30 (2015), 20–26.
5. Koch, C.G., Reineks, E.Z., Tang, A.S., et al. Contemporary bloodletting in cardiac surgical care. Ann Thorac Surg 99 (2015), 779–784.
6. Koch, C.G., Khandwala, F., Li, L., Estafanous, F.G., Loop, F.D., Blackstone, E.H., Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg 82 (2006), 13–20.
7. Koch, C.G., Li, L., Van Wagoner, D.R., Duncan, A.I., Gillinov, A.M., Blackstone, E.H., Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg 82 (2006), 1747–1756.
8. Surgenor, S.D., DeFoe, G.R., Fillinger, M.P., et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 114 (2006), I43–I48.
9. Loor, G., Rajeswaran, J., Li, L., et al. The least of 3 evils: exposure to red blood cell transfusion, anemia, or both?. J Thorac Cardiovasc Surg 146 (2013), 1480–1487.e1486.
10. Prchal, J.T., Clinical manifestations and classification of erythrocyte disorders. Kaushansky, K., Lichtman, M.A., Prchal, J.T., et al. (eds.) Williams Hematology, 9th edition, 2015, McGraw-Hill Education, New York, NY, 503–512.
11. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Information System. 2011, World Health Organization, Geneva, Switzerland Available at http://www.who.int/vmnis/indicators/haemoglobin.pdf Accessed September 11, 2015.
12. Kumar, V., Abbas, A.K., Aster, J.C., Robbins and Cotran Pathologic Basis of Disease. 2015, Elsevier, Philadelphia, PA.
13. Austin, P.C., Mamdani, M.M., A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use. Stat Med 25 (2006), 2084–2106.
14. Baron, D.M., Hochrieser, H., Posch, M., et al. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth 113 (2014), 416–423.
15. De Santo, L., Romano, G., Della Corte, A., et al. Preoperative anemia in patients undergoing coronary artery bypass grafting predicts acute kidney injury. J Thorac Cardiovasc Surg 138 (2009), 965–970.
16. Musallam, K.M., Tamim, H.M., Richards, T., et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 378 (2011), 1396–1407.
17. DeLoughery, T.G., Microcytic anemia. N Engl J Med 371 (2014), 1324–1331.
18. Green, R., Dwyre, D.M., Evaluation of macrocytic anemias. Semin Hematol 52 (2015), 279–286.
19. Salive, M.E., Cornoni-Huntley, J., Guralnik, J.M., et al. Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status. J Am Geriatr Soc 40 (1992), 489–496.
20. Gupta, P.K., Sundaram, A., Mactaggart, J.N., et al. Preoperative anemia is an independent predictor of postoperative mortality and adverse cardiac events in elderly patients undergoing vascular surgery. Ann Surg 258 (2013), 1096–1102.
21. George, J., Patal, S., Wexler, D., et al. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers. Arch Intern Med 165 (2005), 1304–1309.
22. McCullough, P.A., Lepor, N.E., Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease. Rev Cardiovasc Med 6 Suppl 3 (2005), S4–S12.
23. Anand, I.S., Pathophysiology of anemia in heart failure. Heart Fail Clin 6 (2010), 279–288.
24. Kim, C.J., Connell, H., McGeorge, A.D., Hu, R., Prevalence of preoperative anaemia in patients having first-time cardiac surgery and its impact on clinical outcome. A retrospective observational study. Perfusion 30 (2015), 277–283.
25. Ferraris, V.A., Davenport, D.L., Saha, S.P., Austin, P.C., Zwischenberger, J.B., Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 147 (2012), 49–55.
26. Orlov, D., Karkouti, K., The pathophysiology and consequences of red blood cell storage. Anaesthesia 70 Suppl 1 (2015), 29–37 e9–12.
27. Koch, C.G., Figueroa, P.I., Li, L., Sabik, J.F. III, Mihaljevic, T., Blackstone, E.H., Red blood cell storage: how long is too long?. Ann Thorac Surg 96 (2013), 1894–1899.
28. Cohen, B., Matot, I., Aged erythrocytes: a fine wine or sour grapes?. Br J Anaesth 111 Suppl 1 (2013), i62–i70.
29. Goddard, A.F., James, M.W., McIntyre, A.S., Scott, B.B., British Society of Gastroenterology. Guidelines for the management of iron deficiency anaemia. Gut 60 (2011), 1309–1316.
30. Camaschella, C., Iron-deficiency anemia. N Engl J Med 372 (2015), 1832–1843.
31. Onken, J.E., Bregman, D.B., Harrington, R.A., et al. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion 54 (2014), 306–315.
32. Lin, D.M., Lin, E.S., Tran, M.H., Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfus Med Rev 27 (2013), 221–234.
33. Testa, U., Erythropoietic stimulating agents. Expert Opin Emerg Drugs 15 (2010), 119–138.
34. Singh, A.K., Szczech, L., Tang, K.L., et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 (2006), 2085–2098.
35. Pfeffer, M.A., Burdmann, E.A., Chen, C.Y., et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361 (2009), 2019–2032.
36. Stowell, C.P., Jones, S.C., Enny, C., Langholff, W., Leitz, G., An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: safety analysis. Spine (Phila Pa 1976) 34 (2009), 2479–2485.
37. Savage, D.G., Ogundipe, A., Allen, R.H., Stabler, S.P., Lindenbaum, J., Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci 319 (2000), 343–352.
38. Kaferle, J., Strzoda, C.E., Evaluation of macrocytosis. Am Fam Physician 79 (2009), 203–208.
39. Liebman, H.A., Weitz, I.C., Autoimmune hemolytic anemia. Med Clin North Am 101 (2017), 351–359.
40. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Available at https://www.guideline.gov/summaries/summary/46510. Accessed May 29, 2017.